These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 25293758)

  • 21. Pneumolysin: a double-edged sword during the host-pathogen interaction.
    Marriott HM; Mitchell TJ; Dockrell DH
    Curr Mol Med; 2008 Sep; 8(6):497-509. PubMed ID: 18781957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in astrocyte shape induced by sublytic concentrations of the cholesterol-dependent cytolysin pneumolysin still require pore-forming capacity.
    Förtsch C; Hupp S; Ma J; Mitchell TJ; Maier E; Benz R; Iliev AI
    Toxins (Basel); 2011 Jan; 3(1):43-62. PubMed ID: 22069689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival.
    Subramanian K; Neill DR; Malak HA; Spelmink L; Khandaker S; Dalla Libera Marchiori G; Dearing E; Kirby A; Yang M; Achour A; Nilvebrant J; Nygren PÅ; Plant L; Kadioglu A; Henriques-Normark B
    Nat Microbiol; 2019 Jan; 4(1):62-70. PubMed ID: 30420782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acacetin inhibits Streptococcus pneumoniae virulence by targeting pneumolysin.
    Li S; Lv Q; Sun X; Tang T; Deng X; Yin Y; Li L
    J Pharm Pharmacol; 2020 Aug; 72(8):1092-1100. PubMed ID: 32390150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ca²⁺-dependent repair of pneumolysin pores: A new paradigm for host cellular defense against bacterial pore-forming toxins.
    Wolfmeier H; Schoenauer R; Atanassoff AP; Neill DR; Kadioglu A; Draeger A; Babiychuk EB
    Biochim Biophys Acta; 2015 Sep; 1853(9):2045-54. PubMed ID: 25219550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytosolic mtDNA released from pneumolysin-damaged mitochondria triggers IFN-β production in epithelial cells.
    Fang Y; Zhang X; Lu C; Yin Y; Hu X; Xu W; Liu Y; Wang H
    Can J Microbiol; 2020 Jul; 66(7):435-445. PubMed ID: 32191844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Juglone alleviates pneumolysin-induced human alveolar epithelial cell injury via inhibiting the hemolytic activity of pneumolysin.
    Song M; Lu G; Li M; Deng X; Wang J
    Antonie Van Leeuwenhoek; 2017 Aug; 110(8):1069-1075. PubMed ID: 28451868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux.
    Karmakar M; Katsnelson M; Malak HA; Greene NG; Howell SJ; Hise AG; Camilli A; Kadioglu A; Dubyak GR; Pearlman E
    J Immunol; 2015 Feb; 194(4):1763-75. PubMed ID: 25609842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR4 mediates pneumolysin-induced ATF3 expression through the JNK/p38 pathway in Streptococcus pneumoniae-infected RAW 264.7 cells.
    Nguyen CT; Kim EH; Luong TT; Pyo S; Rhee DK
    Mol Cells; 2015 Jan; 38(1):58-64. PubMed ID: 25518930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infiltrated Macrophages Die of Pneumolysin-Mediated Necroptosis following Pneumococcal Myocardial Invasion.
    Gilley RP; González-Juarbe N; Shenoy AT; Reyes LF; Dube PH; Restrepo MI; Orihuela CJ
    Infect Immun; 2016 May; 84(5):1457-69. PubMed ID: 26930705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Domain 4 of pneumolysin from Streptococcus pneumoniae is a multifunctional domain contributing TLR4 activating and hemolytic activity.
    Chiu FF; Leng CH; Ding YJ; Chang JC; Chang LS; Lien SP; Chen HW; Siu LK; Liu SJ
    Biochem Biophys Res Commun; 2019 Oct; 517(4):596-602. PubMed ID: 31395343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clarithromycin Inhibits Pneumolysin Production via Downregulation of
    Domon H; Isono T; Hiyoshi T; Tamura H; Sasagawa K; Maekawa T; Hirayama S; Yanagihara K; Terao Y
    Microbiol Spectr; 2021 Oct; 9(2):e0031821. PubMed ID: 34468195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyruvate oxidase of Streptococcus pneumoniae contributes to pneumolysin release.
    Bryant JC; Dabbs RC; Oswalt KL; Brown LR; Rosch JW; Seo KS; Donaldson JR; McDaniel LS; Thornton JA
    BMC Microbiol; 2016 Nov; 16(1):271. PubMed ID: 27829373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A Streptococcus survival in macrophages.
    Bastiat-Sempe B; Love JF; Lomayesva N; Wessels MR
    mBio; 2014 Sep; 5(5):e01690-14. PubMed ID: 25227466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apigenin protects mice from pneumococcal pneumonia by inhibiting the cytolytic activity of pneumolysin.
    Song M; Li L; Li M; Cha Y; Deng X; Wang J
    Fitoterapia; 2016 Dec; 115():31-36. PubMed ID: 27693741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the structure and mechanism of a bacterial protein toxin by analytical ultracentrifugation and small-angle neutron scattering.
    Gilbert RJ; Heenan RK; Timmins PA; Gingles NA; Mitchell TJ; Rowe AJ; Rossjohn J; Parker MW; Andrew PW; Byron O
    J Mol Biol; 1999 Nov; 293(5):1145-60. PubMed ID: 10547292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia.
    Yuste J; Botto M; Paton JC; Holden DW; Brown JS
    J Immunol; 2005 Aug; 175(3):1813-9. PubMed ID: 16034123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose and Oxygen Levels Modulate the Pore-Forming Effects of Cholesterol-Dependent Cytolysin Pneumolysin from
    Hoffet MS; Tomov NS; Hupp S; Mitchell TJ; Iliev AI
    Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I IFN expression is stimulated by cytosolic MtDNA released from pneumolysin-damaged mitochondria via the STING signaling pathway in macrophages.
    Hu X; Peng X; Lu C; Zhang X; Gan L; Gao Y; Yang S; Xu W; Wang J; Yin Y; Wang H
    FEBS J; 2019 Dec; 286(23):4754-4768. PubMed ID: 31315154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isorhamnetin as a novel inhibitor of pneumolysin against Streptococcus pneumoniae infection in vivo/in vitro.
    Zou Y; Wang H; Fang J; Sun H; Deng X; Wang J; Deng Y; Chi G
    Microb Pathog; 2023 Dec; 185():106382. PubMed ID: 37839759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.